CN1939512B - Infantile overfood dispersing tablets - Google Patents
Infantile overfood dispersing tablets Download PDFInfo
- Publication number
- CN1939512B CN1939512B CN 200510019530 CN200510019530A CN1939512B CN 1939512 B CN1939512 B CN 1939512B CN 200510019530 CN200510019530 CN 200510019530 CN 200510019530 A CN200510019530 A CN 200510019530A CN 1939512 B CN1939512 B CN 1939512B
- Authority
- CN
- China
- Prior art keywords
- parts
- grams
- infantile
- children
- overfood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000463 material Substances 0.000 claims abstract description 19
- 239000003814 drug Substances 0.000 claims description 63
- -1 sucrose fatty acid ester Chemical class 0.000 claims description 62
- 229930006000 Sucrose Natural products 0.000 claims description 61
- 239000007919 dispersible tablet Substances 0.000 claims description 60
- 239000005720 sucrose Substances 0.000 claims description 60
- 239000000194 fatty acid Substances 0.000 claims description 54
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 53
- 229930195729 fatty acid Natural products 0.000 claims description 53
- 239000003826 tablet Substances 0.000 claims description 40
- 239000000284 extract Substances 0.000 claims description 37
- 235000013305 food Nutrition 0.000 claims description 34
- 239000003795 chemical substances by application Substances 0.000 claims description 26
- 239000000843 powder Substances 0.000 claims description 25
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 22
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 22
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 20
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 20
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 20
- 238000002156 mixing Methods 0.000 claims description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 14
- 239000002671 adjuvant Substances 0.000 claims description 12
- 235000019359 magnesium stearate Nutrition 0.000 claims description 10
- 239000002994 raw material Substances 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 239000010271 massa medicata fermentata Substances 0.000 claims description 7
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 6
- 239000008187 granular material Substances 0.000 claims description 6
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 239000007779 soft material Substances 0.000 claims description 5
- 239000000706 filtrate Substances 0.000 claims description 3
- 239000000796 flavoring agent Substances 0.000 claims description 3
- 235000019634 flavors Nutrition 0.000 claims description 3
- 235000010357 aspartame Nutrition 0.000 claims description 2
- 201000006549 dyspepsia Diseases 0.000 abstract description 5
- 206010012735 Diarrhoea Diseases 0.000 abstract description 2
- 206010061428 decreased appetite Diseases 0.000 abstract description 2
- 244000183685 Citrus aurantium Species 0.000 abstract 1
- 235000007716 Citrus aurantium Nutrition 0.000 abstract 1
- 240000005979 Hordeum vulgare Species 0.000 abstract 1
- 235000007340 Hordeum vulgare Nutrition 0.000 abstract 1
- 208000022531 anorexia Diseases 0.000 abstract 1
- 229960004793 sucrose Drugs 0.000 description 60
- 229940031703 low substituted hydroxypropyl cellulose Drugs 0.000 description 18
- 239000011230 binding agent Substances 0.000 description 14
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 13
- 239000000314 lubricant Substances 0.000 description 12
- 239000000945 filler Substances 0.000 description 11
- 239000011734 sodium Substances 0.000 description 11
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 11
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 11
- 238000004090 dissolution Methods 0.000 description 10
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 9
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 9
- 239000001768 carboxy methyl cellulose Substances 0.000 description 9
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 9
- 229920000053 polysorbate 80 Polymers 0.000 description 9
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 9
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 9
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 8
- 238000004132 cross linking Methods 0.000 description 8
- 239000000546 pharmaceutical excipient Substances 0.000 description 8
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 7
- 229920002472 Starch Polymers 0.000 description 7
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 7
- 238000013461 design Methods 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 239000008101 lactose Substances 0.000 description 7
- 229910052708 sodium Inorganic materials 0.000 description 7
- 239000008107 starch Substances 0.000 description 7
- 235000019698 starch Nutrition 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 6
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 6
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 6
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 239000000741 silica gel Substances 0.000 description 5
- 229910002027 silica gel Inorganic materials 0.000 description 5
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 4
- 229930195725 Mannitol Natural products 0.000 description 4
- 230000000954 anitussive effect Effects 0.000 description 4
- 229940124584 antitussives Drugs 0.000 description 4
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 4
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 4
- 239000003995 emulsifying agent Substances 0.000 description 4
- 239000000594 mannitol Substances 0.000 description 4
- 235000010355 mannitol Nutrition 0.000 description 4
- 238000004904 shortening Methods 0.000 description 4
- 241000628997 Flos Species 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 229920000881 Modified starch Polymers 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 235000015243 ice cream Nutrition 0.000 description 3
- 235000013310 margarine Nutrition 0.000 description 3
- 239000003264 margarine Substances 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 102000055006 Calcitonin Human genes 0.000 description 2
- 108060001064 Calcitonin Proteins 0.000 description 2
- 239000004378 Glycyrrhizin Substances 0.000 description 2
- 206010042674 Swelling Diseases 0.000 description 2
- 229960001997 adefovir Drugs 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 description 2
- 229960004015 calcitonin Drugs 0.000 description 2
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 2
- 235000013539 calcium stearate Nutrition 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 229940112822 chewing gum Drugs 0.000 description 2
- 235000015218 chewing gum Nutrition 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 235000014510 cooky Nutrition 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 238000005187 foaming Methods 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 2
- 235000019410 glycyrrhizin Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- 150000002596 lactones Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229920002521 macromolecule Polymers 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- TZBAVQKIEKDGFH-UHFFFAOYSA-N n-[2-(diethylamino)ethyl]-1-benzothiophene-2-carboxamide;hydrochloride Chemical compound [Cl-].C1=CC=C2SC(C(=O)NCC[NH+](CC)CC)=CC2=C1 TZBAVQKIEKDGFH-UHFFFAOYSA-N 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 229940093429 polyethylene glycol 6000 Drugs 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 2
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 2
- 235000012141 vanillin Nutrition 0.000 description 2
- PVHUJELLJLJGLN-INIZCTEOSA-N (S)-nitrendipine Chemical compound CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)[C@@H]1C1=CC=CC([N+]([O-])=O)=C1 PVHUJELLJLJGLN-INIZCTEOSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 208000037147 Hypercalcaemia Diseases 0.000 description 1
- WJHSRFQBVYHKKL-UHFFFAOYSA-N Oroboside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C(C=3C=C(O)C(O)=CC=3)=COC2=C1 WJHSRFQBVYHKKL-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
- DJSISFGPUUYILV-UHFFFAOYSA-N UNPD161792 Natural products O1C(C(O)=O)C(O)C(O)C(O)C1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC(O)=CC=1)O2 DJSISFGPUUYILV-UHFFFAOYSA-N 0.000 description 1
- KGUHOFWIXKIURA-VQXBOQCVSA-N [(2r,3s,4s,5r,6r)-6-[(2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl dodecanoate Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](COC(=O)CCCCCCCCCCC)O[C@@H]1O[C@@]1(CO)[C@@H](O)[C@H](O)[C@@H](CO)O1 KGUHOFWIXKIURA-VQXBOQCVSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 150000004665 fatty acids Chemical group 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 125000001165 hydrophobic group Chemical group 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000000148 hypercalcaemia Effects 0.000 description 1
- 208000030915 hypercalcemia disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- PEFNSGRTCBGNAN-QNDFHXLGSA-N luteolin 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C=C(C=3C=C(O)C(O)=CC=3)OC2=C1 PEFNSGRTCBGNAN-QNDFHXLGSA-N 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N n-hexadecanoic acid Natural products CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 229960005425 nitrendipine Drugs 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 239000003883 ointment base Substances 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000001253 polyvinylpolypyrrolidone Substances 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- DJSISFGPUUYILV-ZFORQUDYSA-N scutellarin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC(O)=CC=1)O2 DJSISFGPUUYILV-ZFORQUDYSA-N 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229940032085 sucrose monolaurate Drugs 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 235000015149 toffees Nutrition 0.000 description 1
- 239000003860 topical agent Substances 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 238000005550 wet granulation Methods 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
A dispersing tablet preferable for baby for treating simple indigestion, anorexia and diarrhea caused by indigestion is prepared from 6 Chinese-medicinal materials including maticated leaven, bitter orange, haw, germinated barley, etc and proper auxiliary.
Description
Technical field
The present invention relates to Chinese patent medicine dispersible tablet technical field, relate in particular to the dispersible tablet that a kind of children's likes food.
Background technology
Dispersible tablet is a kind of novel pharmaceutical formulation that development in recent years is got up, and children's likes the existing multiple dosage form of food, has spleen invigorating, helps digestion the effect of eliminate indigestion.Be used for the treatment of infantile simple dyspepsia, the diarrhoea that inappetence and dyspepsia cause.The children's of one of former dosage form likes the sugar garment piece and has listed Chinese Pharmacopoeia in.It is slow that children's likes the stripping of sugar garment piece, absorption difference, and bioavailability is not high.
Compare ordinary tablet, dispersible tablet requires temperature at the disintegrate medium in 20 ± 1 ℃, and disintegration, the granule after the disintegrate should all sieve by No. 2 less than 3 minutes.It is rapid that medicine has a stripping, absorb fast, the bioavailability height, advantages such as taking convenience can swallow, chew, contain and suck or with taking after the aqueous dispersion, the patient who especially is fit to the old man and the difficulty of swallowing takes.Compare with liquid preparation, it is good that dispersible tablet has a medicine stability, packs, transports, preserves advantage easily.
Can use for this reason that the modern pharmaceutical technology changes its dosage form into both can be oral, can be scattered in the dispersible tablet that forms fragrant and sweet good to eat solution in the water again rapidly.
In fact disintegrate finishes and can not represent medicine well to absorb, and medicine need have good dissolution that good bioavailability height just can be arranged.The dissolution index of dispersible tablet is to investigate the important indicator of dispersible tablet performance.
Comparatively speaking, CMS-Na, LS-HPC, PVPP, CCMC-Na are more outstanding to the contribution of disintegrate, and microcrystalline Cellulose is not obvious to the contribution of disintegrate, and microcrystalline Cellulose is more outstanding to the contribution of dispersibility, dissolution.When the good dispersibility of needs, dissolution, need add a large amount of materials such as microcrystalline Cellulose.For example " center combination design optimization method screening Radix Lamiophlomidis Rotatae dispersible tablet preparation technology "/Chinese Pharmaceutical Journal .2004, the adjuvant of the Radix Lamiophlomidis Rotatae dispersible tablet of 39 (10) .-760-763 record is: 12%PVPP is that disintegrating agent, 14% pregelatinized Starch are that sweller, 3% micropowder silica gel are that lubricant and fluidizer, 45% microcrystalline Cellulose MCC are filler.The dispersible tablet disintegration time for preparing under the optimal conditions is 20.6s, and the t80 of luteoloside stripping is 1.68min, and the suspendible coefficient behind the dispersible tablet suspendible is 0.0689.According to another second section the record on the 763rd page of right side of this article, microcrystalline Cellulose MCC fluctuates in 40%, 45%, 55% scope, and all the time to disintegrate does not make significant difference.Add its purpose of microcrystalline Cellulose significantly and be better to improve Radix Lamiophlomidis Rotatae effective ingredient dissolution.
The most effective traditional dispersible tablet disintegrating agent is carboxymethyl starch sodium (CMS-Na), low-substituted hydroxypropyl cellulose (LS-HPC), crospolyvinylpyrrolidone (PVPP), cross-linking sodium carboxymethyl cellulose (CCMC-Na), combination between them needs satisfied temperature in 20 ± 1 ℃, disintegration is less than 3 minutes, the granule after the disintegrate should be all by the requirement of No. 2 sieves.The disintegrate efficient of CMS-Na, LS-HPC, PVPP, CCMC-Na totally is higher than sodium carboxymethyl cellulose, microcrystalline Cellulose, pregelatinized Starch medicine.The disintegrate principle of CMS-Na, LS-HPC, PVPP, CCMC-Na mainly is a suction back volume swelling significantly, thereby dispersible tablet is collapsed out.
The difference of Western medicine dispersible tablet and dispersible tablets of Chinese medicine is that the industrialization difficulty of dispersible tablets of Chinese medicine is higher, this is because the Chinese medicine dose is big, Western medicine principal agent dose is little, the Western medicine principal agent is generally at below 20% of gross weight of whole dispersible tablet, a lot of below 10%, for example embodiment 1 record of " CN03137976.1 nitrendipine dispersible tablet and preparation method thereof ": dispersible tablet is formed: 150 milligrams of 10 milligrams of nitrendipines and pharmaceutical adjuvants.Embodiment 1,2,3 records of " CN200410012867.5 adefovir ester dispersible tablet and preparation method ": dispersible tablet is formed: adefovir ester 4.2-8.7%, the pharmaceutical adjuvant of surplus.Other Western medicine dispersible tablet patent reports all have similar record.
And dispersible tablets of Chinese medicine is in order to guarantee curative effect, its Chinese medicine principal agent is generally at more than 20% of gross weight of whole dispersible tablet, embodiment 4 records of " 200410014092.5 1 kinds of Flos Trollii novel formulation one Flos Trollii dispersible tablets that are more suitable for child, old man of CN ": dispersible tablet is formed: 333 gram Flos Trollii extracts, 612.5 gram pharmaceutical adjuvants.The most preferred embodiment record of " CN 200410074528.X Yimaikang dispersion tablet and preparation method thereof ": dispersible tablet is formed: Herba Erigerontis extractum 160g, lactose 120g, microcrystalline Cellulose 150g, low-substituted hydroxypropyl cellulose 90g, polyvinylpolypyrrolidone 60g, steviosin, micropowder silica gel, magnesium stearate are a small amount of, and pharmaceutical adjuvant amounts to about 420g.Other dispersible tablets of Chinese medicine patent reports all have similar record.
The principal agent of removing a class dispersible tablets of Chinese medicine is the extraction from the single plant, the situation that its Chinese medicine addition is less, for example " CN 02133464.1 dispersed general arasaponin tablet and its production and application ", " CN 02153445.4 breviscapine dispersible tablet and preparation method thereof ".The principal agent ratio is all up to about 30-50% in the dispersible tablets of Chinese medicine of most compound recipes, rely on remaining pharmaceutical adjuvant to guarantee quick disintegrate in 3 minutes, and to keep suitable dissolution be very very difficult, add that Chinese medicine extract contains macromolecular substances such as pectin, polysaccharide mostly and be attached on the surface when the dispersible tablets of Chinese medicine disintegrate, medicine disintegrate and stripping are caused negative effect.
In sum, most herbal mixture dispersible tablets are because of (1) Chinese medicine principal agent ratio content height, (2) sticking of macromolecular substances such as pectin, polysaccharide causes that the dispersible tablets of Chinese medicine disintegration rate is difficult to reach the requirement that is controlled in 3 minutes, than the more difficult industrialization of Western medicine dispersible tablet.Western medicine dispersible tablet kind in the industrialization of having reported is more, but the dispersible tablets of Chinese medicine kind of industrialization is considerably less.
Therefore transform the form that existing herbal mixture kind makes it to become dispersible tablet, disintegrate is finished in the adjuvant combination that efficiency of selection is higher according to qualifications faster, so that obtain the better medicament bioavailability certain meaning is arranged.
Summary of the invention
The purpose of this invention is to provide a kind of infantile overfood dispersing tablets, conveniently take to better meet needs of medical treatment.
The present invention has also added sucrose fatty acid ester, tween 80 is used to increase Chinese medicine medicine disintegration.
The present invention adds a spot of HLB=15-16 sucrose fatty acid ester and further improves disintegration.A spot of HLB=15-16 sucrose fatty acid ester can shorten tens of seconds disintegration time approximately, can alleviate simple dependence carboxymethyl starch sodium (CMS-Na), low-substituted hydroxypropyl cellulose (LS-HPC), crospolyvinylpyrrolidone (PVPP), cross-linking sodium carboxymethyl cellulose (CCMC-Na) and finish the pressure of disintegrate, make that the design room for maneuver of dispersible tablets of Chinese medicine is bigger, help design and obtain more rational dispersible tablet.
Technical scheme of the present invention has following:
A kind of infantile overfood dispersing tablets, the composition of this dispersible tablet comprise that children's likes food extract, adjuvant; Adjuvant comprises disintegrating agent, filler, binding agent, lubricant, correctives, and children's likes the food extract and made by the following weight Chinese medicinal raw materials: Massa Medicata Fermentata (stir-fry) 20-120, Fructus Aurantii (parched) 10-80, the Rhizoma Atractylodis Macrocephalae (stir-fry) 10-80, Fructus Crataegi 20-100, Fructus Oryzae Germinatus (stir-fry) 150-240, Fructus Hordei Germinatus (stir-fry) 150-240.
Infantile overfood dispersing tablets is made by the following weight Chinese medicinal raw materials: Massa Medicata Fermentata (stir-fry) 77, Fructus Aurantii (parched) 39, the Rhizoma Atractylodis Macrocephalae (stir-fry) 39, Fructus Crataegi 59, Fructus Oryzae Germinatus (stir-fry) 192, Fructus Hordei Germinatus (stir-fry) 192.
Infantile overfood dispersing tablets, each constituent weight proportion is: children's likes food extract 10-80 part, disintegrating agent 10-50 part, filler 0-30 part, binding agent 0-10 part, lubricant 0-8 part, correctives 0-5 part.
Infantile overfood dispersing tablets, each constituent weight proportion is: children's likes food extract 10-40 part, disintegrating agent 10-50 part, filler 0-30 part, binding agent 0-10 part, lubricant 0-8 part, correctives 0-5 part.
The key of dispersible tablet is its disintegration rate in water, so the selection of the disintegrate system in the tablet is extremely important, the disintegrating agent that the present invention chooses is any one or a few in carboxymethyl starch sodium (CMS-Na), low-substituted hydroxypropyl cellulose (LS-HPC), crospolyvinylpyrrolidone (PVPP), cross-linking sodium carboxymethyl cellulose (CCMC-Na), sodium carboxymethyl cellulose, microcrystalline Cellulose, the pregelatinized Starch.
Filler is in order to increasing the weight and volume of dispersible tablet, to be beneficial to molding and divided dose, the filler that the present invention chooses be in lactose, the mannitol any one or a few.
Lubricant be for can feed in raw material smoothly and slice, make the pharmaceutic adjuvant of tablet smooth and beautiful appearance, the lubricant that the present invention chooses be in magnesium stearate, micropowder silica gel, calcium stearate, Pulvis Talci, Stepanol MG, the silicon dioxide any one or a few; Correctives is that A Siba is sweet, in the glycyrrhizin, citric acid, vanillin any one or a few.
Binding agent is to be convenient to wet granulation and the adherent pharmaceutic adjuvant of tabletting, and the binding agent of dispersible tablet of the present invention comprises in polyvinylpyrrolidone (PVP), polyethylene glycol 6000, the Macrogol 4000 any one or a few.But do not use binding agent, and adopt Ethanol Method to prepare soft material, be pressed into dispersible tablet after the pelletize smoothly yet.
Dispersible tablet of the present invention also comprises sucrose fatty acid ester, tween 80, and addition is sucrose fatty acid ester 0.5-2.5 part, tween 80 0-0.5 part of the HLB=15-16 of weight proportion.
Dispersible tablet of the present invention, the model of the sucrose fatty acid ester of interpolation are P-1570 or P-1670 or LWA-1570.
In order to guarantee the stable of principal agent, can also add an amount of antioxidant etc.
Infantile overfood dispersing tablets obtains by following concrete steps: above Six-element, and Fructus Hordei Germinatus and Fructus Oryzae Germinatus decoct with water secondary, and each 30 minutes, collecting decoction filtered, and filtrate is condensed into the thick paste shape; All the other Massa Medicata Fermentatas etc. four flavor is ground into fine powder, and with above-mentioned thick paste mixing, drying under reduced pressure is pulverized and obtained the fine powder that children's likes the food extract, by the equivalent method of progressively increasing children's is liked the fine powder of food extract and the mixture mixing of filler, disintegrating agent, 80 mesh sieves; Material behind the mixing is put in the appropriate containers, adds binding agent, and water or ethanol dissolve in right amount, make soft material; Make wet granular, drying, granulate adds the adjuvant of remainder again, mixing, tabletting promptly gets infantile overfood dispersing tablets.
Disintegrating agent add, add in can adopting or in add and add combination.
Instructions of taking of the present invention is: each 2-5 sheet, every day 2-3 time.
The English of sucrose fatty acid ester is: Sucrose fatty acid esters.Sucrose fatty acid ester also claims fatty acid cane sugar ester, is called for short SE, can be subdivided into mono fatty acid ester, double acid ester and tri-fatty acid ester.Sucrose fatty acid ester is a kind of food additive commonly used, also can be used as the adjuvant of medicine, for example sees the report that sucrose fatty acid ester is used for the Western medicine conventional tablet once in a while.
But the report of rarely found sucrose fatty acid ester also in the dispersible tablets of Chinese medicine field, this be because: sucrose fatty acid ester is because of the raw material sources difference, the technology difference, the difference that monoester, two fat, three fat replace, its HLB is distributed in the broad range of 2-16.Sucrose fatty acid ester of a great variety.For example: sucrose monolaurate, sucrose palmitic acid ester, sucrose hard fatty acid ester S-1,3,5,7,9,11,13,15,16 series, external F-10,20 series, S570,1170 series of producing, kinds such as P-1670, P-1570, LWA-1570.
Wherein the HLB value of P-1670, P-1570, LWA-1570 is respectively 16,15,15.
Suitable sucrose fatty acid ester kind is used for the dispersible tablets of Chinese medicine field also needs to pass through technology screening.
At first using of present domestic sucrose fatty acid ester at most be emulsifying agent in the field of food, be used for bread, cake can prevent to wear out, should use HLB greater than 11 sucrose ester, consumption is 0.2%～0.5% of a Semen Tritici aestivi flour, also can improve foaming effect.Be used for margarine, shortening, ice cream, can improve emulsion stability, should use low HLB value sucrose ester, consumption is 2%～5% of margarine, an oil quantity; Ice cream, 0.1%～0.3%; 0.008%～1.72% of shortening, oil quantity.Be used for chocolate and can suppress crystallization, reduce viscosity, should use the HLB value is 3～9 sucrose ester, and consumption is 0.2%～1.0%.Be used for cookies and can improve shortening property, water-retaining property and anti ageing property, can also reduce cookies at storage, damaged in the transportation and can improve operability, should use the HLB value is 7 sucrose ester, and consumption is 0.1%～0.5%.Be used for the chewing gum base and can make colloid be easy to knead, can prevent that rockiness from varying with temperature, can improve fragrance protectiveness, should use the HLB value is 5～9 sucrose ester, and consumption is 0.5%～3%.Be used for chewing gum, toffee can reduce viscosity, prevents that oil from separating out or crystallization, prevents the tooth that sticks to one's teeth, should use the HLB value is 2～4 sucrose ester, consumption is 5%～10%.
As seen as the food compound mostly use be HLB at the sucrose fatty acid ester 12 below, mainly acting on is emulsifying agent.
Sucrose fatty acid ester records as excipient substance is disclosed: " character: this product for white to the powder or the heavy-gravity liquid of sundown, odorless or special odor is arranged slightly.Heating is then decomposed more than 145 degrees centigrade, and 120 degrees centigrade with next stable.Effect and purposes: this product has effects such as emulsifying, dispersion, solubilising, plasticising, is used as emulsifying agent, dispersant, solubilizing agent, stabilizing agent, thickening agent, the emulsifiable paste matrix of for oral administration and topical agent in medicament.Make the storage library material etc. of the transdermal absorption formulation of medicines such as hormones, anti-inflammatory analgesic class, painstaking effort tubing.This product also is a food additive, is widely used in food industry, is used to make margarine, shortening, ice cream etc., can improve emulsibility, stability, foaming characteristic." it specifically is applied to " fish glycerol, Futrator suppository, ointment base, the suspensoid of sulfur amine thiazole, increase such as the binding agent in the solid orally ingestible of Western medicine such as macrocyclic lactone, disintegrating agent, lubricant dissolution, raising bioavailability.”
" 56.3 milligrams of sucrose fatty acid ester and 6.4 milligrams of mixing of human body calcitonin with HLB11 are prepared into oral mealy medicine, can promote that human body absorbs calcitonin, the treatment hypercalcemia.”
The production and supply of domestic for a long time sucrose fatty acid ester mainly are the sucrose fatty acid ester of low HLB, be mainly used in the emulsifying agent of food or pharmaceuticals industry, and the product rareness of the sucrose fatty acid ester of its high HLB, and quality is stable inadequately, residual free sugar, sour more can't satisfy the strict demand of medical auxiliary materials, causes practical application and scientific research research to lag behind, particularly in the dispersible tablets of Chinese medicine field, the application report of rarely found sucrose fatty acid ester also.
Although the prompting of " sucrose fatty acid ester is used for the binding agent, disintegrating agent, lubricant of the solid orally ingestible ten of Western medicine such as macrocyclic lactone etc. increases dissolution, improves bioavailability " is arranged, specifically use the kind of which kind of classification, also need to pass through technology screening.For example experiment shows that sucrose hard fatty acid ester S-170, sucrose hard fatty acid ester S-570 etc. not only can not shorten disintegration rate, also prolong disintegration rate on the contrary.The sucrose fatty acid ester of HLB11 can not effectively shorten disintegration rate.Have only the kind of HLB 15-16 can effectively shorten disintegration rate.
Can not obviously shorten disintegration rate as the independent use of additive Tween 80 commonly used, but the sucrose hard fatty acid ester coupling of itself and HLB15-16 is remarkably productive, concrete reason is still not detailed.
Sucrose fatty acid ester is to be hydrophilic group with 8 hydroxyl sucrose, is the non-ionic surface active agent of hydrophobic group with the fatty acid part of having replaced the sucrose hydroxyl, forms by sucrose and fatty acid ester exchange reaction.The monoester rate height of the sucrose fatty acid ester of HLB15-16, the greasiness rate is low, and hydroxyl is few by metathetical amount, and good hydrophilic is arranged, and can reduce the tension force on liquid-solid surface, helps medicine to discharge from tablet faster.It is different that its action principle and carboxymethyl starch sodium (CMS-Na), low-substituted hydroxypropyl cellulose (LS-HPC), crospolyvinylpyrrolidone (PVPP), cross-linking sodium carboxymethyl cellulose dependence water absorption and swellings such as (CCMC-Na) are finished the principle of disintegrate.
Therefore relying on the sucrose hard fatty acid ester of a spot of HLB 15-16 to assist a large amount of carboxymethyl starch sodium, low-substituted hydroxypropyl cellulose, crospolyvinylpyrrolidone, cross-linking sodium carboxymethyl cellulose to accelerate the disintegrate of dispersible tablets of Chinese medicine, is that those of ordinary skill is difficult for expecting.
Various sucrose hard fatty acid esters are to the influence of disintegration rate:
Do the disintegration time experiment by 2000 editions officinal requirements.The product of each model is respectively got 6, calculates average disintegration time.
| P-1670 | HLB16 | 46％ | 6％ | 36％ | 134.5 |
| LWA-1570 | HLB15 | 46％ | 6％ | 36％ | 134.9 |
Sucrose hard fatty acid ester in this table is provided by Mitsubishi-Kagaku Foods Corp..To in the same old way disintegration time is 163.7 seconds.
Chinese medicine in this table is selected from the fine powder of infantile heat-clearing and antitussive extract.
The enlightenment that obtains thus is, has only the sucrose hard fatty acid ester of HLB 15-16 can shorten the disintegration time of infantile heat-clearing and antitussive dispersible tablets of Chinese medicine.Because of the sucrose hard fatty acid ester of HLB below 15 do not have actively and significantly effect the disintegration time that shortens dispersible tablets of Chinese medicine, can reject the sucrose hard fatty acid ester of HLB below 15.
Although it is variant that infantile heat-clearing and antitussive and children's like the herbal species of food, we think that the sucrose hard fatty acid ester of HLB 15-16 should have similarity to the influence that infantile heat-clearing and antitussive and children's like the food disintegration time.Below test has also proved this trend.
Get sucrose hard fatty acid ester and Tween 80 and investigate it likes the disintegration time of food dispersible tablets of Chinese medicine to children's influence.The product of each model is respectively got 6, calculates average disintegration time.
The present invention adds a spot of HLB=14-16 sucrose fatty acid ester can also improve dissolution.A spot of HLB=14-16 sucrose fatty acid ester can substitute more microcrystalline Cellulose, is used with other adjuvants, and it is better than microcrystalline Cellulose to the efficient that improves dissolution.Help reducing the consumption of microcrystalline Cellulose, vacate more interpolation space, make that the design room for maneuver of dispersible tablets of Chinese medicine is bigger, help design and obtain more rational dispersible tablet.
The more space of adding makes that the design room for maneuver of dispersible tablets of Chinese medicine is bigger, helps design and obtains more rational dispersible tablet.
The specific embodiment:
Embodiment 1:
The raw material of Chinese medicine of infantile overfood dispersing tablets: Massa Medicata Fermentata (stir-fry) 77 grams, Fructus Aurantii (parched) 39 grams, the Rhizoma Atractylodis Macrocephalae (stir-fry) 39 grams, Fructus Crataegi 59 grams, Fructus Oryzae Germinatus (stir-fry) 192 grams, Fructus Hordei Germinatus (stir-fry) 192 grams.
The Chinese medicine extract of infantile overfood dispersing tablets and auxiliary material percentage by weight: children's likes the fine powder 25% of food extract, carboxymethyl starch sodium 36%, low-substituted hydroxypropyl cellulose 8%, microcrystalline Cellulose 8%, lactose 18%, polyvinylpyrrolidone 3%, magnesium stearate 2%.
Infantile overfood dispersing tablets obtains by following concrete steps: above Six-element, and Fructus Hordei Germinatus and Fructus Oryzae Germinatus decoct with water secondary, and each 30 minutes, collecting decoction filtered, and filtrate is condensed into the thick paste shape; Four flavors such as all the other Massa Medicata Fermentatas are ground into fine powder, and with above-mentioned thick paste mixing, drying under reduced pressure is pulverized and obtained the fine powder that children's likes the food extract.
Earlier above-mentioned material is crossed 100 mesh sieves respectively, by the equivalent method of progressively increasing children's is liked the fine powder of food extract and the mixture mixing of filler, disintegrating agent, the material behind the mixing is put in the appropriate containers, the adding binding agent, and water or ethanol dissolve in right amount, make soft material; 20 mesh sieves are made wet granular, drying, and 20 mesh sieve granulate add the adjuvant of remainder again, mixing, tabletting promptly gets infantile overfood dispersing tablets.
Embodiment 2:
The children's of percentage by weight likes the fine powder 30.4% of food extract, sodium carboxymethyl cellulose 21.8%, microcrystalline Cellulose 15.4%, crospolyvinylpyrrolidone 15.4%, polyvinylpyrrolidone 6.6%, lactose 5%, polyvinylpyrrolidone 3.3%, micropowder silica gel 0.9%, Stepanol MG 1.2%.All the other are with embodiment 1.
Embodiment 3:
The children's of percentage by weight likes the fine powder 40.3% of food extract, carboxymethyl starch sodium 25.8%, cross-linking sodium carboxymethyl cellulose 11.7%, crospolyvinylpyrrolidone 2.9%, low-substituted hydroxypropyl cellulose 7.5%, mannitol 4.5%, polyvinylpyrrolidone 2.9%, micropowder silica gel 2.2%, magnesium stearate 1%, the sucrose fatty acid ester 1.2% of HLB=15-16.Sucrose fatty acid ester is P-1570 or P-1670 or LWA-1570, and all the other are with embodiment 1.
Embodiment 4:
The raw material of Chinese medicine of infantile overfood dispersing tablets: Massa Medicata Fermentata (stir-fry) 120 grams, Fructus Aurantii (parched) 10 grams, the Rhizoma Atractylodis Macrocephalae (stir-fry) 80 grams, Fructus Crataegi 20 grams, Fructus Oryzae Germinatus (stir-fry) 240 grams, Fructus Hordei Germinatus (stir-fry) 150 grams.
The Chinese medicine extract of infantile overfood dispersing tablets and auxiliary material weight proportion: children's likes 10 parts of the fine powders of food extract, 10 parts of disintegrating agents, 5 parts of filleies.Disintegrating agent is a low-substituted hydroxypropyl cellulose, and filler is a lactose.All the other are with embodiment 1.
Embodiment 5:
The raw material of Chinese medicine of infantile overfood dispersing tablets: Massa Medicata Fermentata (stir-fry) 20 grams, Fructus Aurantii (parched) 80 grams, the Rhizoma Atractylodis Macrocephalae (stir-fry) 10 grams, Fructus Crataegi 100 grams, Fructus Oryzae Germinatus (stir-fry) 150 grams, Fructus Hordei Germinatus (stir-fry) 240 grams.
The Chinese medicine extract of infantile overfood dispersing tablets and auxiliary material weight proportion: children's likes 80 parts of the fine powders of food extract, 50 parts of disintegrating agents, 30 parts of filleies, 10 parts of binding agents, 8 parts of lubricants, 5 parts of correctivess.
Disintegrating agent is 35 parts of low-substituted hydroxypropyl celluloses, 15 parts of cross-linking sodium carboxymethyl celluloses, filler is 10 parts of lactose, 20 parts in mannitol, binding agent is a polyethylene glycol 6000, lubricant is 2 parts of calcium stearates, 2 parts of Pulvis Talci, 4 parts of silicon dioxide, and correctives is 1 part of glycyrrhizin, 3 parts of citric acids, 1 part of vanillin.All the other are with embodiment 1.
Embodiment 6:
The raw material of Chinese medicine of infantile overfood dispersing tablets: Massa Medicata Fermentata (stir-fry) 77 grams, Fructus Aurantii (parched) 39 grams, the Rhizoma Atractylodis Macrocephalae (stir-fry) 39 grams, Fructus Crataegi 59 grams, Fructus Oryzae Germinatus (stir-fry) 192 grams, Fructus Hordei Germinatus (stir-fry) 192 grams.
The Chinese medicine extract of infantile overfood dispersing tablets and auxiliary material weight proportion: children's likes 40 parts of the fine powders of food extract, 30 parts of disintegrating agents, 25 parts of filleies, 5 parts of binding agents, 3 parts of lubricants, 2 parts of correctivess.
Disintegrating agent is 25 parts of low-substituted hydroxypropyl celluloses, 5 parts of cross-linking sodium carboxymethyl celluloses, and filler is a mannitol, and binding agent is a Macrogol 4000, and lubricant is 2 parts of magnesium stearate, 1 part of Stepanol MG, and correctives is that A Siba is sweet.All the other are with embodiment 1.
Embodiment 7:
The Chinese medicine extract of infantile overfood dispersing tablets and auxiliary material weight ratio: children's likes 48 parts of the fine powders of food extract, 12 parts of crospolyvinylpyrrolidone, 34 parts of microcrystalline Cellulose, 5.5 parts of low-substituted hydroxypropyl celluloses, 0.5 part of magnesium stearate.All the other are with embodiment 1.
Embodiment 8:
One group of infantile overfood dispersing tablets:
(1) Chinese medicine extract of infantile overfood dispersing tablets and auxiliary material weight ratio: children's likes fine powder 47.6*2=95.2 part of food extract, low-substituted hydroxypropyl cellulose 6.2*2=12.4 part, microcrystalline Cellulose 34.3*2=68.6 part, crospolyvinylpyrrolidone 11.4*2=22.8 part, magnesium stearate 0.5*2=1 part.Prepare 100 altogether, every 2.0 gram.All the other are with embodiment 1.
If conversion is weight percentage: children's likes the fine powder 47.6% of food extract, low-substituted hydroxypropyl cellulose 6.2%, microcrystalline Cellulose 34.3%, crospolyvinylpyrrolidone 11.4%, magnesium stearate 0.5%.
(2) Chinese medicine extract of infantile overfood dispersing tablets and auxiliary material weight ratio: children's likes 16.7 parts of the fine powders of food extract, 3.4 parts of low-substituted hydroxypropyl celluloses, 37.2 parts of microcrystalline Cellulose, 8.2 parts of crospolyvinylpyrrolidone, 34.5 parts of lactose.Prepare 100 altogether, every 1 gram.All the other are with embodiment 1.
(3) Chinese medicine extract of infantile overfood dispersing tablets and auxiliary material weight ratio: children's likes 31.2 parts of the fine powders of food extract, 4.2 parts of low-substituted hydroxypropyl celluloses, 32.5 parts of microcrystalline Cellulose, 30.1 parts of crospolyvinylpyrrolidone, 1.2 parts of aspartames, 0.8 part of magnesium stearate.Earlier above-mentioned material is crossed 100 mesh sieves respectively, children's is liked the fine powder and the disintegrating agent mixing of food extract by the equivalent method of progressively increasing, material behind the mixing is put in the appropriate containers, adds ethanol and dissolves in right amount, and make soft material: 20 mesh sieves are made wet granular, dry, 20 mesh sieve granulate add the adjuvant of remainder, mixing again, tabletting promptly gets infantile overfood dispersing tablets.All the other are with embodiment 1.
Embodiment 9:
Infantile overfood dispersing tablets, the model of also adding sucrose fatty acid ester are 2.5 parts of P-1570.0.3 part of tween 80.All the other repeat above-mentioned all embodiment respectively.
Embodiment 10:
Infantile overfood dispersing tablets, the model of also adding sucrose fatty acid ester are 0.5 part of P-1570,0.5 part of tween 80.All the other repeat above-mentioned all embodiment respectively.
Embodiment 11:
Infantile overfood dispersing tablets, the model of also adding sucrose fatty acid ester are 2.5 parts of P-1670.0.3 part of tween 80.All the other repeat above-mentioned all embodiment respectively.
Embodiment 12:
Infantile overfood dispersing tablets, the model of also adding sucrose fatty acid ester are 0.5 part of P-1670,0.5 part of tween 80.All the other repeat above-mentioned all embodiment respectively.
Embodiment 13:
Infantile overfood dispersing tablets, the model of also adding sucrose fatty acid ester are 2.0 parts of P-1570.All the other repeat above-mentioned all embodiment respectively.
Embodiment 14:
Infantile overfood dispersing tablets, the model of also adding sucrose fatty acid ester are 0.5 part of P-1670.All the other repeat above-mentioned all embodiment respectively.
Claims (1)
1. an infantile overfood dispersing tablets is characterized in that the composition of this dispersible tablet comprises that children's likes food extract, adjuvant; Extract and adjuvant weight ratio: children's likes 31.2 parts of the fine powders of food extract, 4.2 parts of low-substituted hydroxypropyl celluloses, 32.5 parts of microcrystalline Cellulose, 30.1 parts of crospolyvinylpyrrolidone, 1.2 parts of aspartames, 0.8 part of magnesium stearate, model are 2.0 parts of the sucrose fatty acid ester of P-1570;
Earlier above-mentioned material is crossed 100 mesh sieves respectively, by the equivalent method of progressively increasing children's is liked fine powder and the disintegrating agent mixing of eating extract, the material behind the mixing is put in the appropriate containers, adds ethanol and dissolves in right amount, makes soft material; 20 mesh sieves are made wet granular, drying, and 20 mesh sieve granulate add the adjuvant of remainder again, mixing, tabletting promptly gets infantile overfood dispersing tablets;
The fine powder that children's likes the food extract obtains through the following steps: the raw material of Chinese medicine of infantile overfood dispersing tablets: Fructus Oryzae Germinatus 192 grams of the Rhizoma Atractylodis Macrocephalae 39 grams of Massa Medicata Fermentata 77 grams of parch, Fructus Aurantii 39 grams of parch, parch, Fructus Crataegi 59 grams, parch, Fructus Hordei Germinatus 192 grams of parch; Above Six-element, Fructus Hordei Germinatus and Fructus Oryzae Germinatus decoct with water secondary, and each 30 minutes, collecting decoction filtered, and filtrate is condensed into the thick paste shape; Four flavors such as all the other Massa Medicata Fermentatas are ground into fine powder, and with above-mentioned thick paste mixing, drying under reduced pressure is pulverized and obtained the fine powder that children's likes the food extract.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510019530 CN1939512B (en) | 2005-09-30 | 2005-09-30 | Infantile overfood dispersing tablets |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510019530 CN1939512B (en) | 2005-09-30 | 2005-09-30 | Infantile overfood dispersing tablets |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1939512A CN1939512A (en) | 2007-04-04 |
| CN1939512B true CN1939512B (en) | 2011-01-12 |
Family
ID=37958214
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200510019530 Expired - Fee Related CN1939512B (en) | 2005-09-30 | 2005-09-30 | Infantile overfood dispersing tablets |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1939512B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103271206A (en) * | 2013-05-14 | 2013-09-04 | 胡和秀 | Digestion helping lozenge sugar |
| CN103704559B (en) * | 2013-12-31 | 2015-12-30 | 陈慧婷 | Chinese yam, lotus seed and malt dispersible tablet and preparation method thereof |
| CN111920916B (en) * | 2020-06-30 | 2022-04-19 | 贵州益佰女子大药厂有限责任公司 | Preparation method of children's favorite effervescent tablets |
| CN117919352B (en) * | 2024-02-06 | 2024-05-28 | 吉林华康药业股份有限公司 | Pharmaceutical composition for improving immunity of children |
| CN119258029A (en) * | 2024-12-10 | 2025-01-07 | 江中药业股份有限公司 | A pharmaceutical composition capable of improving the compression ratio of children's favorite tablets and a preparation method thereof |
-
2005
- 2005-09-30 CN CN 200510019530 patent/CN1939512B/en not_active Expired - Fee Related
Non-Patent Citations (2)
| Title |
|---|
| 国家药典委员会.小儿喜食颗粒.国家药品标准.2002, * |
| 蔡治纲等.中药分散片研究进展.中成药.2004, * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1939512A (en) | 2007-04-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106975069A (en) | A kind of liver protecting composition and preparation method thereof | |
| CA1094451A (en) | Method of controlling fecal output and compositions therefor | |
| CN105769970A (en) | Siraitia grosvenorii chewable tablets and preparation method thereof | |
| CN1939512B (en) | Infantile overfood dispersing tablets | |
| KR20250029839A (en) | Pharmaceutical composition containing pelagonium sidoides extracts, and preparing method thereof | |
| CN1939358A (en) | Sarcandra glaber dispersant tablets | |
| CN102085344B (en) | Aplotaxis carminative sustained-release preparation and preparation method thereof | |
| CN1939449B (en) | Infantile heat-clearing and antitussive dispersing tablets | |
| CN1939430B (en) | Dispersing tablets for clearing heat,purging fire and detoxifying | |
| CN1939471B (en) | Wuji Baifeng dispersing tablet | |
| CN1939423A (en) | Rhizoma corydalis analgetic dispersing tablet | |
| JP2003002831A (en) | Ameliorating agent for female hormone abnormality disorder | |
| CN1939355A (en) | Ginkgo dispersing tablets | |
| CN1939399A (en) | Blood stream-breaking dispersing tablets | |
| CN1315498C (en) | Effervescence tablet for quickly allaying infantile fever and its preparation method | |
| CN1939407A (en) | Dispersant tablets of honeysuckle flower and coptis | |
| CN104013696A (en) | Plant medicine composition for preventing and treating metabolic syndrome and application thereof | |
| JP2000116356A (en) | Antiallergic food and antiallergic agent | |
| JP2618286B2 (en) | Hypotensive yeast preparation and its production method | |
| CN1872327B (en) | Composition of medicine for treating diarrhea | |
| CN1939478A (en) | Dispersing tablets against cervicitis | |
| CN104126838B (en) | A kind of food of clearing away the heart fire and tranquillizing, health products or pharmaceutical composition | |
| JP3356732B2 (en) | Tablet and method for producing the same | |
| CN111528386B (en) | Hawthorn and natto solid beverage and preparation method thereof | |
| KR102402571B1 (en) | Method for Making Chewable Tablet Containing Red Ginseng |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110112 Termination date: 20110930 |